ListedMainboardSULA
SULA VINEYARDS LIMITED
SULA VINEYARDS LIMITED is a mainboard IPO raising ₹960 Cr at ₹340 – ₹357 a share. It listed on 22 Dec 2022 and trades at ₹160 today, −55.1% against its issue price of ₹357. It was subscribed 2.33× in total.
₹357
Issue price
₹160
Price now
−55.1%
Since issue price
22 Dec 2022
Listed on
2.33×Subscribed (final) · all exchanges
2.3 times more demand than shares on offer
populated partly populated we hold nothing here — the tab says why
Who bid for it
| Investor category | Shares offered | Shares bid for | Subscribed |
|---|---|---|---|
| QIB Banks, funds and other large institutions | 53,80,106 | 2,22,40,512 | 4.13× |
| Foreign Institutional Investors | no separate quota | 99,77,814 | n/a |
| Domestic Financial Institutions | no separate quota | 61,06,044 | n/a |
| Mutual funds | no separate quota | 46,79,262 | n/a |
| Others | no separate quota | 14,77,392 | n/a |
| Non-institutional Wealthy individuals and companies bidding above ₹2 lakh | 40,35,080 | 60,88,446 | 1.51× |
| Non Institutional Investors | 26,90,053 | 45,39,066 | 1.69× |
| Corporates | no separate quota | 16,85,838 | n/a |
| Individuals | no separate quota | 27,57,132 | n/a |
| Others | no separate quota | 96,096 | n/a |
| Non Institutional Investors | 13,45,027 | 15,49,380 | 1.15× |
| Corporates | no separate quota | 13,230 | n/a |
| Individuals | no separate quota | 13,95,282 | n/a |
| Others | no separate quota | 1,40,868 | n/a |
| Retail Ordinary investors bidding up to ₹2 lakh | 94,15,186 | 1,55,07,996 | 1.65× |
| Cut Off | no separate quota | 1,36,65,582 | n/a |
| Price bids | no separate quota | 18,42,414 | n/a |
| Total | 1,88,30,372 | 4,38,36,954 | 2.33× |
Sub-categories read no separate quota rather than a dash: the exchange publishes bids at that level but never a reservation against them, so a subscription multiple does not exist — it is not missing data. Bids across both exchanges (NSE and BSE) — the figure usually quoted publicly. Last updated 25 Jul, 07:18 pm IST.
How demand built
We hold no subscription readings for this issue.